A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

BACKGROUND: Transarterial chemoembolisation (TACE) has not been shown to be superior to bland embolisation (TAE) for treatment of hepatocellular carcinoma (HCC). METHODS: We conducted a randomised phase II/III trial in patients with untreated HCC. Patients were randomised to TAE with polyvinyl alcoh...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, T, Kirkwood, A, Roughton, M, Beare, S, Tsochatzis, E, Yu, D, Davies, N, Williams, E, Pereira, S P, Hochhauser, D, Mayer, A, Gillmore, R, O'Beirne, J, Patch, D, Burroughs, A K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619271/
https://www.ncbi.nlm.nih.gov/pubmed/23449352
http://dx.doi.org/10.1038/bjc.2013.85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619271/
https://www.ncbi.nlm.nih.gov/pubmed/23449352
http://dx.doi.org/10.1038/bjc.2013.85

Ejemplares similares